阿司匹林抵抗的现实情况探讨(3)
[14] Taylor DW,Barnett HJ,Haynes RB,et al. low-dose and high-dose acetylsalicy acid and for patients unedrgoing carotid endarterectomy:a randomized controlled trial:AsA and Carotid Endarterectomy (ACE) Trial collaborators[J]. Lancet,1999,353: 2179-2184.
[15] Carson SN,Pemling RH,Esquivel CO. Aspirin failure in symptomatic atherosclerotic carotid artery disease[J].Surgery, 1981, 90:1084-1092.
[16] Patrono C, Coller B, Dalen JE, et al. Platelet-active druys:the relationships amoxg dose,effectiveness ,and side effects[J]. chest,2001,119:395- 635.
[17] Roth GJ,Stanford N,Majerus Pw.Acetylation of prostaglandin synthase by asprin[J]. Proc Natl Acad Sci USA,1975,72:3073-3076.
[18] Patrignani P, Filabozzip,PatronoC. Selective Cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subject[J]. J Clin Invest,1982,69:1366-1372.
[19] Reilly IA;FitzGerald GA. Inhibition of thromboxame formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs[J].Blood,1987,69:180-186.
[20]Vane JR.Bakhle YS,Botting Rm.Cyclooxy genese 1and 2[J].AnnRev pharmacol Toxicol,1998,38:97-120.
[21] Weber AA, Zimmermann KC, Meyer-kirchrath J, et al.Cyclooxgenase-2 inhuman platelets as a possible factor in aspirin resistance[J]. lancet, 1999,353:900.
[22] Helgason CM, Tortorice KL,Winkler SR,et al.Aspirin response and failure in cerebral infarction[J]. stroke,1993,24:345-350.
[23] Gum PA Kottke-Marchant K,Piggio ED,et al.Aspirin response and failure in cerebral infarction[J]. Stroke,1993,24:345-350.
[24] FitzGerald GA.Mechanisms of platelet activation:thromboxane A2 as an amplifying signal for other agonists[J]. Am J Cardiol.1991;68:11B-15B., 百拇医药
[15] Carson SN,Pemling RH,Esquivel CO. Aspirin failure in symptomatic atherosclerotic carotid artery disease[J].Surgery, 1981, 90:1084-1092.
[16] Patrono C, Coller B, Dalen JE, et al. Platelet-active druys:the relationships amoxg dose,effectiveness ,and side effects[J]. chest,2001,119:395- 635.
[17] Roth GJ,Stanford N,Majerus Pw.Acetylation of prostaglandin synthase by asprin[J]. Proc Natl Acad Sci USA,1975,72:3073-3076.
[18] Patrignani P, Filabozzip,PatronoC. Selective Cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subject[J]. J Clin Invest,1982,69:1366-1372.
[19] Reilly IA;FitzGerald GA. Inhibition of thromboxame formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs[J].Blood,1987,69:180-186.
[20]Vane JR.Bakhle YS,Botting Rm.Cyclooxy genese 1and 2[J].AnnRev pharmacol Toxicol,1998,38:97-120.
[21] Weber AA, Zimmermann KC, Meyer-kirchrath J, et al.Cyclooxgenase-2 inhuman platelets as a possible factor in aspirin resistance[J]. lancet, 1999,353:900.
[22] Helgason CM, Tortorice KL,Winkler SR,et al.Aspirin response and failure in cerebral infarction[J]. stroke,1993,24:345-350.
[23] Gum PA Kottke-Marchant K,Piggio ED,et al.Aspirin response and failure in cerebral infarction[J]. Stroke,1993,24:345-350.
[24] FitzGerald GA.Mechanisms of platelet activation:thromboxane A2 as an amplifying signal for other agonists[J]. Am J Cardiol.1991;68:11B-15B., 百拇医药